1.
|
Jacobs AH and Walton RG: The incidence of
birthmarks in the neonate. Pediatrics. 58:218–222. 1976.PubMed/NCBI
|
2.
|
Boye E, Yu Y, Paranya G, Mulliken JB,
Olsen BR and Bischoff J: Clonality and altered behavior of
endothelial cells from hemangiomas. J Clin Invest. 107:745–752.
2001. View
Article : Google Scholar : PubMed/NCBI
|
3.
|
Mulliken JB: Cutaneous vascular anomalies.
Semin Vasc Surg. 6:204–218. 1993.PubMed/NCBI
|
4.
|
Bischoff J: Monoclonal expansion of
endothelial cells in hemangioma: an intrinsic defect with extrinsic
consequences? Trends Cardiovasc Med. 12:220–224. 2002. View Article : Google Scholar : PubMed/NCBI
|
5.
|
Walter JW, North PE, Waner M, Mizeracki A,
Blei F, Walker JW, Reinisch JF and Marchuk DA: Somatic mutation of
vascular endothelial growth factor receptors in juvenile
hemangioma. Genes Chromosomes Cancer. 33:295–303. 2002. View Article : Google Scholar : PubMed/NCBI
|
6.
|
Mendiratta V and Jabeen M: Infantile
hemangioma: an update. Indian J Dermatol Venereol Leprol.
76:469–475. 2010. View Article : Google Scholar : PubMed/NCBI
|
7.
|
Mabeta P and Pepper MS: Hemangiomas -
current therapeutic strategies. Int J Dev Biol. 55:431–437. 2011.
View Article : Google Scholar : PubMed/NCBI
|
8.
|
Itinteang T, Withers AH, Leadbitter P, Day
DJ and Tan ST: Pharmacologic therapies for infantile hemangioma: is
there a rational basis? Plast Reconstr Surg. 128:499–507. 2011.
View Article : Google Scholar : PubMed/NCBI
|
9.
|
Peng Q, Liu W, Zhou F, Wang Y and Ji Y: An
experimental study on the therapy of infantile hemangioma with
recombinant interferon γ. Pediatr Surg. 46:496–501. 2011.PubMed/NCBI
|
10.
|
Elmore S: Apoptosis: a review of
programmed cell death. Toxicol Pathol. 35:495–516. 2007. View Article : Google Scholar : PubMed/NCBI
|
11.
|
Budihardjo I, Oliver H, Lutter M, et al:
Biochemical pathways of caspase activation during apoptosis. Annu
Rev Cell Dev Biol. 15:269–290. 1999. View Article : Google Scholar : PubMed/NCBI
|
12.
|
Léauté-Labrèze C, Dumas de la Roque E,
Hubiche T, Boralevi F, Thambo JB and Taïeb A: Propranolol for
severe hemangiomas of infancy. N Engl J Med. 358:2649–2651.
2008.PubMed/NCBI
|
13.
|
Bertrand J, Sammour R, McCuaig C, Dubois
J, Hatami A, Ondrejchak S, Boutin C, Bortoluzzi P, Laberge LC and
Powell J: Propranolol in the treatment of problematic infantile
hemangioma: review of 35 consecutive patients from a vascular
anomalies clinic. J Cutan Med Surg. 16:317–323. 2012.
|
14.
|
Zegpi-Trueba MS, Abarzúa-Araya A,
Silva-Valenzuela S, Navarrete-Dechent C, Uribe-González P and
Nicklas-Díaz C: Oral propranolol for treating infantile
hemangiomas: a case series of 57 patients. Actas Dermosifiliogr.
103:708–717. 2012. View Article : Google Scholar : PubMed/NCBI
|
15.
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
|
16.
|
Izadpanah A, Izadpanah A, Kanevsky J,
Belzile E and Schwarz K: Propranolol versus corticosteroids in the
treatment of infantile hemangioma: a systematic review and
meta-analysis. Plast Reconstr Surg. 131:601–613. 2013. View Article : Google Scholar : PubMed/NCBI
|
17.
|
Zhang D, Ma Q, Shen S and Hu H: Inhibition
of pancreatic cancer cell proliferation by propranolol occurs
through apoptosis induction: the study of beta-adrenoceptor
antagonist’s anticancer effect in pancreatic cancer cell. Pancreas.
38:94–100. 2009.PubMed/NCBI
|
18.
|
Wong A, Hardy KL, Kitajewski AM, Shawber
CJ, Kitajewski JK and Wu JK: Propranolol accelerates adipogenesis
in hemangioma stem cells and causes apoptosis of hemangioma
endothelial cells. Plast Reconstr Surg. 130:1012–1021. 2012.
View Article : Google Scholar : PubMed/NCBI
|
19.
|
Ji Y, Li K, Xiao X, Zheng S, Xu T and Chen
S: Effects of propranolol on the proliferation and apoptosis of
hemangioma-derived endothelial cells. J Pediatr Surg. 47:2216–2223.
2012. View Article : Google Scholar : PubMed/NCBI
|
20.
|
Kroemer G, Galluzzi L and Brenner C:
Mitochondrial membrane permeabilization in cell death. Physiol Rev.
87:99–163. 2007. View Article : Google Scholar : PubMed/NCBI
|
21.
|
Neamati N, Fernandez A, Wright S, Kiefer J
and McConkey DJ: Degradation of lamin B1 precedes oligonucleosomal
DNA fragmentation in apoptotic thymocytes and isolated thymocyte
nuclei. J Immunol. 154:3788–3795. 1995.PubMed/NCBI
|
22.
|
Sethi G, Shanmugam MK, Ramachandran L,
Kumar AP and Tergaonkar V: Multifaceted link between cancer and
inflammation. Biosci Rep. 32:1–15. 2012. View Article : Google Scholar : PubMed/NCBI
|